Phase I/II study of Y-90-clivatuzumab tetraxetan (Y-90-hPAM4) combined with gemcitabine (Gem) in advanced pancreatic cancer (APC): Final results. Meeting Abstract

cited authors

  • Ocean, Allyson J.; Guarino, Michael J.; Pennington, Kenneth L.; Springett, Gregory M.; Gulec, Seza A.; Bekaii-Saab, Tanios S.; Montero, Alberto J.; Mitchell, Edith P.; Kauh, John S.; Sung, Max W.; Gold, David V.; Horne, Heather; Wegener, William A.; Goldenberg, David M.

fiu authors

publication date

  • 2012

published in


  • 30


  • 15

research area

  • Oncology  Web of Science Research Area